IL6 and head and neck squamous cell carcinoma: Subsequent blocking of IL-6 with the humanized anti-IL-6 antibody MEDI5117 after transplantation of HNSCC patient-derived xenografts into SCID mice successfully reduced CSCs within tumors [59].